Published in Cancer Res on June 01, 1993
The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev (2013) 3.40
Targeting NRF2 signaling for cancer chemoprevention. Toxicol Appl Pharmacol (2009) 1.88
Haploinsufficiency of SGO1 results in deregulated centrosome dynamics, enhanced chromosomal instability and colon tumorigenesis. Cell Cycle (2012) 1.71
Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutr Cancer (2002) 1.49
Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats. Cancer Res (2009) 1.03
Dithiolethiones for cancer chemoprevention: where do we stand? Mol Cancer Ther (2008) 0.98
Adiponectin deficiency enhances colorectal carcinogenesis and liver tumor formation induced by azoxymethane in mice. World J Gastroenterol (2008) 0.88
Chemoprevention of colorectal cancer. Gut (1998) 0.88
Interactions of the major metabolite of the cancer chemopreventive drug oltipraz with cytochrome c: a novel pathway for cancer chemoprevention. Free Radic Biol Med (2007) 0.82
Sphingosine kinase 1 expression enhances colon tumor growth. J Transl Med (2017) 0.75
I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy. Clin Pharmacol Ther (2009) 5.01
Group-specific antigen expression during embryogenesis of the genome of the C-type RNA tumor virus: implications for ontogenesis and oncogenesis. Proc Natl Acad Sci U S A (1970) 3.71
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res (1998) 3.11
Genotoxicity and carcinogenicity in rats and mice of 2-amino-3,6-dihydro-3-methyl-7H-imidazolo[4,5-f]quinolin-7- one: an intestinal bacterial metabolite of 2-amino-3-methyl-3H-imidazo[4,5-f]quinoline. J Natl Cancer Inst (1994) 2.21
Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res (1977) 2.15
Randomized clinical trial of multimodal optimization of surgical care in patients undergoing major colonic resection. Br J Surg (2005) 2.13
Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res (1999) 2.13
Chemoprevention of colonic aberrant crypt foci in Fischer rats by sulforaphane and phenethyl isothiocyanate. Carcinogenesis (2000) 2.06
Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps. Cancer (1977) 2.03
Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res (1995) 1.96
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res (2000) 1.84
Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology (1996) 1.81
Microflora and deconjugation of bile acids in alkaline reflux after partial gastrectomy. Am J Surg (1980) 1.78
Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res (1996) 1.77
Large-bowel carcinogenesis: fecal constituents of populations with diverse incidence rates of colon cancer. J Natl Cancer Inst (1973) 1.70
The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers. Carcinogenesis (1998) 1.59
Sequence analysis of VP4 and VP7 genes of nontypeable strains identifies a new pair of outer capsid proteins representing novel P and G genotypes in bovine rotaviruses. Virology (2000) 1.55
Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis (1993) 1.54
Assay of C-type virus infectivity by measurement of RNA-dependent DNA polymerase activity. Virology (1972) 1.53
Promoting effect of sodium deoxycholate on colon adenocarcinomas in germfree rats. J Natl Cancer Inst (1976) 1.52
Wheat bran and psyllium diets: effects on N-methylnitrosourea-induced mammary tumorigenesis in F344 rats. J Natl Cancer Inst (1996) 1.50
Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev (1999) 1.49
Lepromatous leprosy with extensive truncal seborrheic keratoses and acral verruca vulgaris. Int J Dermatol (1994) 1.49
Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res (1995) 1.48
Murine C-type RNA virus from spontaneous neoplasms: in vitro host range and oncogenic potential. Science (1973) 1.48
Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff. Cancer Res (1986) 1.45
Review article: bacterial translocation in the critically ill--evidence and methods of prevention. Aliment Pharmacol Ther (2007) 1.45
Diet and excretion of bile acids. Cancer Res (1981) 1.44
Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. Cancer Res (2001) 1.41
Bayesian monitoring of phase II trials in cancer chemoprevention. J Clin Epidemiol (1999) 1.41
Statistical analysis of animal cancer chemoprevention experiments. Biometrics (1993) 1.41
Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res (1997) 1.41
Retinoids in chemoprevention and differentiation therapy. Carcinogenesis (2000) 1.38
Balloon mitral valvuloplasty with bifoil catheter: immediate and long-term follow-up results. Cathet Cardiovasc Diagn (1998) 1.38
Naturally occurring sarcoma virus of the BALB/cCr mouse. J Natl Cancer Inst (1974) 1.38
Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: influence of amount and source of dietary fat. J Natl Cancer Inst (1984) 1.37
Colon carcinogenesis with azoxymethane and dimethylhydrazine in germ-free rats. Cancer Res (1975) 1.35
Nutrition and its relationship to cancer. Adv Cancer Res (1980) 1.29
16S ribosomal DNA terminal restriction fragment pattern analysis of bacterial communities in feces of rats fed Lactobacillus acidophilus NCFM. Appl Environ Microbiol (2001) 1.28
Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects. Gastroenterology (1993) 1.27
Fecal profiles of anaerobic microflora of large bowel cancer patients and patients with nonhereditary large bowel polyps. Cancer Res (1978) 1.24
Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon. Cancer Res (1993) 1.22
Dysproteinemia, proteinuria, and glomerulonephritis. Kidney Int (2006) 1.20
Conformational flexibility in DNA structure as revealed by structural studies of drug intercalation and its broader implications in understanding the organization of DNA in chromatin. Cold Spring Harb Symp Quant Biol (1978) 1.20
Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis (1993) 1.20
Activation and isolation of hamster-specific C-type RNA viruses from tumors induced by cell cultures transformed by chemical carcinogens. Proc Natl Acad Sci U S A (1971) 1.18
Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res (1997) 1.17
The biological significance of tobacco-specific N-nitrosamines: smoking and adenocarcinoma of the lung. Crit Rev Toxicol (1996) 1.17
Intestinal disaccharidase activities in the growing germfree and conventional rats. Arch Biochem Biophys (1966) 1.17
Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology (1999) 1.16
Chemoprevention of colon carcinogenesis by organosulfur compounds. Cancer Res (1993) 1.15
Iron and copper utilization in rabbits as affected by diet and germfree status. J Nutr (1965) 1.14
Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis (2000) 1.14
Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res (1995) 1.14
Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res (1997) 1.13
Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases. Cancer Res (1995) 1.13
Metabolic epidemiology of colorectal cancer. Cancer (1974) 1.12
Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res (1994) 1.12
Metabolic epidemiology of large bowel cancer: fecal bulk and constituents of high-risk North American and low-risk Finnish population. Cancer (1978) 1.12
Surrogate anatomic/functional sites for evaluating cancer risk: an extension of the field effect. Clin Cancer Res (1999) 1.12
Prevalence of endogenous type-C virus in normal hamster tissues and hamster tumors induced by chemical carcinogens, simian virus 40, and polyoma virus. J Natl Cancer Inst (1974) 1.11
Bacterial translocation studied in 927 patients over 13 years. Br J Surg (2006) 1.11
Effects of high risk and low risk diets for colon carcinogenesis on fecal microflora and steroids in man. J Nutr (1975) 1.11
Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Cancer Res (1999) 1.10
Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis (1999) 1.10
Modulation of apoptosis by cigarette smoke and cancer chemopreventive agents in the respiratory tract of rats. Carcinogenesis (2001) 1.10
Pancreatic enzymes in germfree and conventional rats fed chemically defined, water-soluble diet free from natural substrates. J Nutr (1969) 1.10
Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis (1997) 1.09
Complete inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate. Cancer Epidemiol Biomarkers Prev (1996) 1.08
Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. Cancer Res (1997) 1.08
Use of in vitro assays to predict the efficacy of chemopreventive agents in whole animals. J Cell Biochem Suppl (1996) 1.08
Effects of dietary fat level and dimethylhydrazine on fecal acid and neutral sterol excretion and colon carcinogenesis in rats. J Natl Cancer Inst (1974) 1.08
Effect of dietary fish oil on azoxymethane-induced colon carcinogenesis in male F344 rats. Cancer Res (1986) 1.07
A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res (2000) 1.07
Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast. Cancer Epidemiol Biomarkers Prev (2001) 1.07
Enhancement of experimental colon cancer by genistein. Cancer Res (1997) 1.07
Dietary fat and its relationship to large bowel cancer. Cancer Res (1981) 1.06
Image morphometric nuclear grading of intraepithelial neoplastic lesions with applications to cancer chemoprevention trials. Cancer Epidemiol Biomarkers Prev (1999) 1.06
Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myo-inositol. Carcinogenesis (2000) 1.06
Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder. Carcinogenesis (1996) 1.06
Natural immunity in mice to structural polypeptides of endogenous type C RNA viruses. J Virol (1976) 1.06
Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis (2000) 1.05
Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. Int J Oncol (2001) 1.05
Dose-response study of the carcinogenicity of tobacco-specific N-nitrosamines in F344 rats. J Cancer Res Clin Oncol (1984) 1.05
Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific carcinogen: caffeine as an important constituent. Cancer Res (1998) 1.05
Fecal bacterial beta-glucuronidase: control by diet. Science (1974) 1.04
Visualization of drug-nucleic acid interactions at atomic resolution. IV. Structure of an aminoacridine--dinucleoside monophosphate crystalline complex, 9-aminoacridine--5-iodocytidylyl (3'--5') guanosine. J Mol Biol (1979) 1.04
Effect of cholesterol metabolites and promoting effect of lithocholic acid in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res (1979) 1.04
beta-kinked DNA--a structure that gives rise to drug intercalation and DNA breathing--and its wider significance in determining the premelting and melting behavior of DNA. Cold Spring Harb Symp Quant Biol (1983) 1.04
Chemopreventive effect of squalene on colon cancer. Carcinogenesis (1998) 1.03
Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCI Chemoprevention Drug Development Program. J Cell Biochem Suppl (1994) 1.03